Identification and classification of differentially expressed genes in renal cell carcinoma by expression profiling on a global human 31,500-element cDNA array.

We investigated the changes in gene expression accompanying the development and progression of kidney cancer by use of 31,500-element complementary DNA arrays. We measured expression profiles for paired neoplastic and noncancerous renal epithelium samples from 37 individuals. Using an experimental design optimized for factoring out technological and biological noise, and an adapted statistical test, we found 1738 differentially expressed cDNAs with an expected number of six false positives. Functional annotation of these genes provided views of the changes in the activities of specific biological pathways in renal cancer. Cell adhesion, signal transduction, and nucleotide metabolism were among the biological processes with a large proportion of genes overexpressed in renal cell carcinoma. Down-regulated pathways in the kidney tumor cells included small molecule transport, ion homeostasis, and oxygen and radical metabolism. Our expression profiling data uncovered gene expression changes shared with other epithelial tumors, as well as a unique signature for renal cell carcinoma. [Expression data for the differentially expressed cDNAs are available as a Web supplement at http://www.dkfz-heidelberg.de/abt0840/whuber/rcc.]

[1]  F. Mostofi,et al.  Histological Typing of Kidney Tumours , 2002 .

[2]  S. Sikka,et al.  In vivo gene expression profile analysis of metallothionein in renal cell carcinoma. , 2000, Cancer letters.

[3]  Martin Vingron,et al.  Processing and quality control of DNA array hybridization data , 2000, Bioinform..

[4]  M Vingron,et al.  GeneNest: automated generation and visualization of gene indices. , 2000, Trends in genetics : TIG.

[5]  A. Brazma,et al.  Gene expression data analysis , 2000, FEBS letters.

[6]  Christian A. Rees,et al.  Molecular portraits of human breast tumours , 2000, Nature.

[7]  N. Sampas,et al.  Molecular classification of cutaneous malignant melanoma by gene expression profiling , 2000, Nature.

[8]  M. Ashburner,et al.  Gene Ontology: tool for the unification of biology , 2000, Nature Genetics.

[9]  Christian A. Rees,et al.  Systematic variation in gene expression patterns in human cancer cell lines , 2000, Nature Genetics.

[10]  Ash A. Alizadeh,et al.  Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling , 2000, Nature.

[11]  J. Mesirov,et al.  Molecular classification of cancer: class discovery and class prediction by gene expression monitoring. , 1999, Science.

[12]  J. Knoll,et al.  PDZK1, a novel PDZ domain-containing protein up-regulated in carcinomas and mapped to chromosome 1q21, interacts with cMOAT (MRP2), the multidrug resistance-associated protein. , 1999, Laboratory investigation; a journal of technical methods and pathology.

[13]  Christian A. Rees,et al.  Distinctive gene expression patterns in human mammary epithelial cells and breast cancers. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[14]  U. Alon,et al.  Broad patterns of gene expression revealed by clustering analysis of tumor and normal colon tissues probed by oligonucleotide arrays. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[15]  P. Schirmacher,et al.  Inverse regulation of vascular endothelial growth factor and VHL tumor suppressor gene in sporadic renal cell carcinomas is correlated with vascular growth: an in vivo study on 29 tumors , 1999, Journal of Molecular Medicine.

[16]  A. Kossakowska,et al.  Expression of matrix metalloproteinases (MMP‐2 and ‐9) and tissue inhibitors of metalloproteinases (TIMP‐1 and ‐2) in acute myelogenous leukaemia blasts: comparison with normal bone marrow cells , 1999, British journal of haematology.

[17]  T. Sugimura,et al.  Identification of receptor genes in renal cell carcinoma associated with angiogenesis by differential hybridization technique. , 1999, Biochemical and biophysical research communications.

[18]  H. Moch,et al.  High-throughput tissue microarray analysis to evaluate genes uncovered by cDNA microarray screening in renal cell carcinoma. , 1999, The American journal of pathology.

[19]  D. Botstein,et al.  Cluster analysis and display of genome-wide expression patterns. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[20]  G. Doig,et al.  Metallothionein expression in renal cancer. , 1998, Urology.

[21]  M Vingron,et al.  Transcriptional profiling on all open reading frames of Saccharomyces cerevisiae , 1998, Yeast.

[22]  V. Lehto,et al.  Extracellular matrix in renal cell carcinomas. , 1998, Histology and histopathology.

[23]  F. Waldman,et al.  EGF‐r gene copy number changes in renal cell carcinoma detected by fluorescence in situ hybridization , 1998, The Journal of pathology.

[24]  B. Delahunt,et al.  The Heidelberg classification of renal cell tumours , 1997, The Journal of pathology.

[25]  B. Delahunt,et al.  Classification of renal cell carcinoma , 1997, Cancer.

[26]  L. Sobin,et al.  TNM staging of renal cell carcinoma , 1997, Cancer.

[27]  Y. Fukushima,et al.  An imprinted gene p57KIP2 is mutated in Beckwith–Wiedemann syndrome , 1996, Nature Genetics.

[28]  A. Feinberg,et al.  Imprinting of the gene encoding a human cyclin-dependent kinase inhibitor, p57KIP2, on chromosome 11p15. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[29]  C. Auffray,et al.  The I.M.A.G.E. Consortium: an integrated molecular analysis of genomes and their expression. , 1996, Genomics.

[30]  H. Baloglu,et al.  Tissue sialic acid and fibronectin levels in human prostatic cancer. , 1996, Cancer letters.

[31]  H. Baloglu,et al.  Tissue fibronectin levels of human prostatic cancer, as a tumor marker. , 1995, Cancer biochemistry biophysics.

[32]  G. Niehans,et al.  Epidermal growth factor receptor and transforming growth factor alpha expression in papillary and nonpapillary renal cell carcinoma: correlation with metastatic behavior and prognosis. , 1995, Clinical cancer research : an official journal of the American Association for Cancer Research.

[33]  S. Elledge,et al.  p57KIP2, a structurally distinct member of the p21CIP1 Cdk inhibitor family, is a candidate tumor suppressor gene. , 1995, Genes & development.

[34]  J. Massagué,et al.  Cloning of p57KIP2, a cyclin-dependent kinase inhibitor with unique domain structure and tissue distribution. , 1995, Genes & development.

[35]  Lager Dj,et al.  The expression of epidermal growth factor receptor and transforming growth factor alpha in renal cell carcinoma. , 1994 .

[36]  J. Brooks,et al.  Mutations of the VHL tumour suppressor gene in renal carcinoma , 1994, Nature Genetics.

[37]  F. Oesch,et al.  Carbohydrate metabolism in human renal clear cell carcinomas. , 1992, Laboratory investigation; a journal of technical methods and pathology.

[38]  S. Jhanwar,et al.  Histopathological, cytogenetic, and molecular characterization of renal cortical tumors. , 1991, Cancer research.

[39]  S. Maeda,et al.  Amplification and overexpression of the epidermal growth factor receptor gene in human renal‐cell carcinoma , 1990, International journal of cancer.

[40]  T. Shuin,et al.  Enhanced expression of c-myc and epidermal growth factor receptor (C-erbB-1) genes in primary human renal cancer. , 1988, Cancer research.

[41]  J. Haines,et al.  Von Hippel–Lindau disease maps to the region of chromosome 3 associated with renal cell carcinoma , 1988, Nature.

[42]  V. Turk,et al.  Genealogy of mammalian cysteine proteinase inhibitors , 1985, FEBS letters.

[43]  D. Patterson,et al.  Translocation of c-myc in the hereditary renal cell carcinoma associated with a t(3;8)(p14.2;q24.13) chromosomal translocation. , 1985, Proceedings of the National Academy of Sciences of the United States of America.

[44]  S. Fuhrman,et al.  Prognostic significance of morphologic parameters in renal cell carcinoma , 1982, The American journal of surgical pathology.

[45]  L. Penland,et al.  Use of a cDNA microarray to analyse gene expression patterns in human cancer , 1996, Nature Genetics.

[46]  W. Linehan,et al.  Genetic basis of renal cell cancer. , 1993, Important advances in oncology.